Australia's Mayne Pharma gains as quarterly loss narrows

Mayne Pharma

29/04/2026 03:39

** Shares of Australia's Mayne Pharma MYX.AX rise 10.8% to A$2.98, on track for their highest closing level since January 13

** Stock is among the top-gainers on the ASX All Ordinaries Index .AORD

** Pharma firm posts third-quarter underlying EBITDA loss of A$1.4 million, 57% lower than the prior corresponding period

** It added that the company continues to examine capital allocation strategies, which may include an on-market share buy-back

** Co posts Q3 revenue of A$85.2 million, a 1% rise from the prior corresponding period

** MYX down 2.6% YTD

(Reporting by Keshav Singh Chundawat in Bengaluru)

((Keshav.singhchundawat@thomsonreuters.com))